Use access key #2 to skip to page content.
$6.36 0.16 (2.58%)
7/23/2008 4:00 PM

Stereotaxis, Inc. (STXS)

CAPS Rating:
**

The Company designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite, or cath lab.

View All Commentary (STXS)

Recs

1

Avatar alolio (< 20) Submitted: 10/24/06 12:09 AM : Outperform Start Price: $12.10 STXS Score: -41.08

The technology that Stereotaxis employs is excellent, revolutionary even, and if they can keep up with the pace of technology that they have set there is excellent potential for this company to do well. On the down side, it is a very expensive piece of capital equipment that will depend on sales of either service contracts or proprietary products to keep a revenue stream flowing. That said, there are many ways in which Stereotaxis can be partnered with other, existing technologies that will greatly expand the usefullness and longevity of its products.

Report this Post Replies: 0 | Reply

Featured Broker Partners